Drug intelligence / Profile preview

neomycin sulfate + bacitracin zinc + hydrocortisone acetate + polymyxin b sulfate

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Neomycin sulfate + bacitracin zinc + hydrocortisone acetate + polymyxin b sulfate is a fixed-dose **ophthalmic ointment** combining three topical antibiotics with a corticosteroid for steroid-responsive inflammatory ocular conditions in which bacterial infection is present or there is a risk of bacterial infection. Neomycin inhibits bacterial protein synthesis by binding the 30S ribosomal subunit, polymyxin B disrupts the outer membrane of susceptible Gram-negative bacteria, bacitracin interferes with bacterial cell-wall synthesis, and hydrocortisone acetate provides local anti-inflammatory glucocorticoid activity. The product has been marketed under brands including **Neo-Polycin HC** and historically **Cortisporin Ophthalmic Ointment**, and is now available as a multisource generic ophthalmic steroid-anti-infective combination used for conditions involving the conjunctiva, cornea, anterior segment inflammation, chronic anterior uveitis, infective conjunctivitis, and corneal injury associated with burns or foreign bodies.

Brand names
Neo-Polycin HCCortisporin
Other names
neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ophthalmic ointmentneomycin sulfate + bacitracin zinc + hydrocortisone acetate + polymyxin b sulfate ophthalmic ointment
02

Targets

GR (Glucocorticoid receptor)Bacterial Ribosome

Beyond the preview

Go deeper on neomycin sulfate + bacitracin zinc + hydrocortisone acetate + polymyxin b sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + bacitracin zinc + hydrocortisone acetate + polymyxin b sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call